Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Best Option?

<< Previous

Bullboard Posts

Next >>

Post by longterm56on Jan 12, 2021 9:53am

216 Views

Post# 32274919

Best Option?

One of the reports from SPCEO talking to the CEO awhile back said that Paul said "we have alot of options for raising cash. " So we have to choose one of the following: 1) they didn't choose the best option and therefore made a bad decision. 2) they were compelled to make this deal to move forward 3) this was the best option Since #2 is really the same as #3 there are really only two choices. I have to go with #3 realizing that I don't know all the details.

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?